Safety and efficacy of sacubitril/valsartan in patients with heart failure with mildly reduced or preserved EF after a worsening heart failure event based on diuretic use in PARAGLIDE-HF

Back

HFA Premium Access

Safety and efficacy of sacubitril/valsartan in patients with heart failure with mildly reduced or preserved EF after a worsening heart failure event based on diuretic use in PARAGLIDE-HF

Session: Chronic heart failure - treatment 11

Topic: Pharmacotherapy

Speaker: Doctor S. Chatur (Boston, US)

Event: Heart Failure 2024

Congress Presentation

About the speaker

Doctor Safia Chatur

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

0 follower

6 more presentations in this session

Initial experience with vericiguat treatment in real life. VERITA registry versus the VICTORIA study.

Speaker: Doctor M. Groba Marco (Las Palmas de Gran Canaria, ES)

Outpatient treatment of heart failure decompensation with subcutaneous furosemide

Speaker: Mrs A. Robles Mezcua (Malaga, ES)

Iron deficiency and supplementation in patients with heart failure: results from the IRON-HF international survey

Speaker: Doctor F. Ballacci (Rome, IT)

Urinary sodium excretion dynamics in heart failure patients

Speaker: Doctor H. Unlugenc (Izmir, TR)

Optimizing heart failure management: initiating medical therapy in patients with mild ejection fraction depression post-acute coronary syndrome

Speaker: Mr A. Rocha De Almeida (Evora, PT)

Access the full session

Chronic heart failure - treatment 11

Speakers: Doctor S. Chatur, Doctor M. Groba Marco, Mrs A. Robles Mezcua, Doctor F. Ballacci, Doctor H. Unlugenc...

Access

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources